The ?Tumor-induced Osteomalacia: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031? report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Tumor-induced Osteomalacia.
Liên Minh Okwin
Dongze
ĐÁ GÀ TrỰc TiẾp Thomo
Kokholm Shoemaker
Atalkvietnam
Rossen Westh
Gentry Acevedo
Bowers Appel
Post Harrison
Simone Lennon